Nrf2 is required for suppressing osteoclast RANKL-induced differentiation in RAW 264.7 cells via inactivating cannabinoid receptor type 2 with AM630
Sign Up to like & getrecommendations! Published in 2020 at "Regenerative Therapy"
DOI: 10.1016/j.reth.2020.02.001
Abstract: Objective Nuclear factor-erythroid 2-related factor 2 (Nrf2) is shown to as a negative-regulatory cause in osteoclasts differentiation. Cannabinoid receptor type 2 (CB2) is verified to regulate osteoclast differentiation, though with diversed results. Methods In current… read more here.
Keywords: raw 264; am630; osteoclast differentiation; cannabinoid receptor ... See more keywords